Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence

NCT01175941 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Fecal Incontinence

Interventions

DRUG: NRL001
DRUG: Placebo control

Sponsor

Norgine